Updated Cochrane Review Assesses COVID-19 Rapid Test Accuracy
The review shows that rapid antigen tests are better at correctly identifying cases of COVID-19 in people with symptoms than in people without symptoms.
Read MorePosted by Melanie Hamilton-Basich | May 10, 2021 | Covid 19 |
The review shows that rapid antigen tests are better at correctly identifying cases of COVID-19 in people with symptoms than in people without symptoms.
Read MorePosted by Melanie Hamilton-Basich | May 7, 2021 | Covid 19 |
Watchmaker Genomics and Molecular Loop have announced a collaboration to accelerate the commercialization of streamlined, high-stringency genetic testing for pathogen surveillance.
Read MorePosted by Melanie Hamilton-Basich | May 5, 2021 | Cancer, Molecular Diagnostics |
John Theurer Cancer Center will perform molecular profiling of all solid tumors or hematologic cancers, where it can help treatment decisions.
Read MorePosted by Melanie Hamilton-Basich | May 5, 2021 | Prenatal Testing |
As part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.
Read MorePosted by Melanie Hamilton-Basich | May 4, 2021 | Company News |
Myriad Genetics has entered into a definitive agreement to sell select operating assets and intellectual property, including the Vectra test, from Myriad Autoimmune’s business unit to Labcorp for $150 million in cash.
Read More